# Ally Financial Inc. (ALLY) — Financial Analysis

**Exchange:** NYSE  
**Coverage as of:** 2026-Q2  
**Updated:** 2026-05-28  
**Tier:** Free primer (step 2 of 19)  
**Sibling pages:** /stocks/ALLY/thesis · /stocks/ALLY/memo

## Financial Snapshot

---
ticker: ALLY
step: 04
title: Financial Quality (incl. Adversarial Sweep)
source: coverage-next-full
generated: 2026-05-28
---

### Step 04 — Financial Quality

#### Section 1 — Statement Quality Assessment

##### Revenue Recognition
- **Net Interest Income**: Recognized accrual-basis on loan and investment portfolios. ALLY follows standard GAAP for banks (Topic 326 / CECL). No unusual revenue-recognition complexity [S1].
- **Insurance premiums**: Recognized over the contract period (VSC contracts) — multi-year amortization. Conservative approach.
- **Securitization gains/losses**: ALLY uses sale-of-financial-assets treatment for off-balance sheet securitizations; recognizes gain at securitization in some cases. Minimal in recent years.

##### Provision for Credit Losses (CECL)
- ALLY adopted CECL effective Jan 1, 2020, which led to one-time $1.2B day-1 reserve build. Since then, ACL has been managed dynamically based on portfolio composition + macroeconomic forecast.
- **2025 ACL**: $3.49B vs. $3.71B FY2024 (modest release as credit normalizes)
- **Methodology**: Discounted cash flow with quarterly reasonable & supportable forecast; uses Moody's economic forecasts as primary input
- **Critical accounting estimate**: Reserve methodology is heavily dependent on used-vehicle pricing forecast (Manheim) — sensitivity disclosed in 10-K Item 7A

##### Operating Leases
- ALLY runs an ~$8B operating lease portfolio (vehicles leased to consumers via dealers)
- Residual value assumptions are critical — currently positioned conservatively post-2022 used-car spike
- Reset of residuals each year flows through depreciation/G&A; not "earnings management" risk

##### Tax Accounting
- ALLY's effective tax rate has been unusually low (~15-20%) in recent years due to:
  - Energy tax credits (Insurance subsidiary investment in renewables)
  - State tax planning + capital-loss carryforwards
- This is sustainable but adds optionality — a normalized 22-24% effective rate would compress EPS by ~10%

#### Section 2 — Quality Adjustments

| Adjustment | Direction | Magnitude | Reasoning |
|---|---|---|---|
| Add back: 2025 credit-card divestiture costs | + EPS | ~$0.50 | One-time strategic action |
| Subtract: Insurance investment gains (volatile) | - EPS | ~$0.30 trailing | Smooth for trend |
| Tax-rate normalization | - EPS | ~$0.25 | Move ETR from 15% → 22% |
| AOCI marks (mark-to-market vol) | Equity adj | $1-2B | Smoothed over the cycle, but currently a drag |

**Adjusted FY2025 EPS** ≈ $2.30-2.50 (close to reported $2.37). Reported earnings are not materially polished — quality of earnings is HIGH.

#### Section 3 — Adversarial Research Sweep (Mandatory)

##### Short Reports
- **No prominent short-seller reports** on ALLY in recent years
- ALLY's short interest is typically ~3-5% of float (modest — not a heavily-shorted name)
- Brief sell-side bear notes have focused on (1) auto credit risk and (2) AOCI volatility, but no fraud-related allegations

##### SEC Investigations / Enforcement Actions
- No active SEC enforcement actions disclosed in FY2025 10-K Item 3 (Legal Proceedings) [S1]
- Historical: 2013 LIBOR-related settlement (pre-Ally branding era); legacy GMAC subprime mortgage settlements (2014); all resolved

##### Material Lawsuits
- **GAP waiver class action** (auto F&I product) — settled in prior years
- **Discriminatory pricing lawsuits** related to dealer markups — settled with CFPB/DOJ in 2013 ($98M); compliance regime well-established since
- **Standard putative class actions** on terms and disclosures — no individually material exposures disclosed
- 10-K Item 3 quantifies aggregate exposure as "not material" in management's view

##### Restatement History
- **No financial-statement restatements in the last 7+ years**
- ALLY's auditor (Deloitte & Touche LLP since 2009) has issued clean opinions consistently
- Internal control over financial reporting (ICFR) deemed effective in every annual filing

##### Auditor & Audit Committee Issues
- Deloitte & Touche has been ALLY's auditor since 2009; long tenure but not a flag for a bank-holding-co (continuity valued by Fed)
- No reported critical audit matters (CAMs) suggesting accounting risk
- Audit Committee composed of independent directors with relevant financial expertise

##### Whistleblower / Insider Issues
- No disclosed whistleblower complaints affecting financial reporting
- Recent insider activity is buying-direction (CEO + CFO purchases Jan 2026) — opposite of distress signal

##### Regulatory Investigations
- Active: standard CFPB exam cycle (auto-finance practices)
- No Fed CCAR objections in recent cycles
- No FDIC enforcement actions on Ally Bank
- 2024 CFPB rulemaking around F&I products — ALLY has navigated without material impact

##### Adverse Media
- 2024-2025 media focused on **auto credit cycle** (legitimate cyclical risk; not malfeasance)
- 2026 media on **subprime auto delinquency record** (industry-level, not ALLY-specific)
- 2025 media on **credit-card divestiture** (positioned as strategic simplification, not capital pressure)

##### Forensic Accounting Red Flags (DuPont / Beneish-style)
| Metric | ALLY FY2025 | Flag? |
|---|---|---|
| Days sales outstanding change | N/A (bank) | — |
| Days payable outstanding change | N/A (bank) | — |
| Gross margin trend | NIM rising (3.48% Q1 2026 vs 3.30% Q1 2025) | OK |
| Effective tax rate trend | 15-20% (low but explained) | OK |
| Working capital churn | N/A (bank) | — |
| Goodwill / intangibles change | Stable ~$0.1B (very small) | OK |
| Asset growth vs. equity growth | Assets +2.2% / Equity +11.5% (FY25) | OK (capital build) |
| Off-balance-sheet exposure trend | AART securitizations stable | OK |

**No forensic red flags identified.**

#### Section 4 — Conservative Accounting Indicators

| Indicator | Status | Notes |
|---|---|---|
| Reserve coverage (ACL/loans) | 2.7% | High; conservative for prime book |
| Operating lease residuals | Conservative since 2022 reset | Demonstrated by lease income stability |
| Goodwill amortization / impairment history | No write-downs | Clean intangibles |
| Tax-rate consistency | Low but stable | Explained by tax credits, not aggressive planning |
| Off-balance-sheet (securitization) | Modest, well-disclosed | AART trusts disclosed quarterly |

#### Section 5 — Earnings Quality Snapshot

- **GAAP EPS FY2025**: $2.37
- **Adjusted Pre-Tax Pre-Provision (PPNR) FY2025**: $2.52B → ~$8.05 per share pretax-pre-provision EPS
- **Provision normalization** (NCO ~ $1.7B annual run-rate) ≈ $5.50 EPS underlying earnings power
- **Tax-rate normalization** (to 22-24%) shaves ~10%
- **Normalized through-cycle EPS estimate**: $5.00–5.50 per share

Current $2.37 EPS reflects (a) elevated credit costs working through, (b) credit-card divestiture friction, (c) AOCI drag on tangible equity. As these normalize, true earnings power is ~$5+ per share, supporting the consensus $4.50-5.00 FY2026E.

#### Section 6 — Cash vs. Reported Earnings Reconciliation

For banks, OCF is dominated by loan book + investment-portfolio swings — less informative than for industrials. The cleaner test:

| Metric | FY2025 |
|---|---|
| Net Income | $852M |
| + Provision for credit losses | $1.20B (net; gross NCO $1.72B less reserve release) |
| - Net Charge-Offs | -$1.72B |
| + Other non-cash items | + $0.5B (depreciation, SBC, etc.) |
| **Pre-Working-Capital Operating CF** | ~$0.84B |
| OCF (XBRL) | $3.73B |

The OCF >> Net Income gap is from balance-sheet working-capital swings (deposit growth, loan paydowns). For valuation, use earnings × multiple, not DCF on OCF.

#### Section 7 — One-Time Charges & Items

##### FY2024-2025 Notable
- **Credit-card divestiture**: ~$0.30B in transaction costs + transition-related charges in 2025
- **Ally Lending wind-down**: Modest restructuring costs in 2024-2025
- **AOCI cumulative**: -$1.5B mark on AFS securities still working off

##### Pre-2024
- **CECL day-1 reserve build** ($1.2B in Q1 2020) — long resolved
- **COVID provision spike** (FY2020 $1.44B) — long resolved
- **Originating-IPO costs** (2014 GMAC → ALLY transition) — long resolved

#### Section 8 — Conclusions

ALLY's financial reporting quality is **HIGH**. No restatements, no SEC enforcement, no short-seller reports, no auditor concerns, no forensic red flags. The accounting is straightforward bank-CECL with no unusual revenue-recognition or off-balance-sheet complexity beyond standard securitization.

**Quality scores**:
- Accounting conservatism: HIGH (CECL reserves above peer average; conservative lease residuals)
- Disclosure quality: HIGH (excellent MD&A and segment reporting; clear capital-action communication)
- Earnings power vs. reported: Reported EPS UNDERSTATES through-cycle earnings power by ~50% (cyclical trough)

**Things to verify in /complete-coverage**:
- Item 7A (quantitative + qualitative market risk) for NIM sensitivity
- Note on CECL methodology for forward-loss assumption
- Capital plan disclosure (CCAR submission expected in 2026)

#### Source Index

[S1] 10-K FY2025 (Items 3, 7, 7A, 8) — accession 0000040729-26-000005
[S2] Q1 2026 10-Q + 8-K
[S3] CFPB / DOJ enforcement actions database (historical; current clean)
[S4] DEF 14A 2026 (auditor disclosure)

## Deeper Financial Analysis

The fundamental tier ($1.00) adds 8 dimensions not included here:

- Revenue Breakdown — segment revenue, geographic mix, product-line margins
- Financial Trends — QoQ momentum, leading indicators, inflection points
- Balance Sheet — debt structure, dilution risk, working capital dynamics
- Capital Allocation — ROIC, buyback cadence, reinvestment efficiency
- Earnings Analysis — beats/misses, guidance vs actuals, transcript highlights
- Competitive Positioning — market share, pricing power, peer benchmarks
- Industry Context — TAM, sector tailwinds/headwinds, regulatory backdrop

**API endpoint:** GET /api/v1/research/ALLY/fundamental

## Navigation

- Overview: /stocks/ALLY
- Financials (this page): /stocks/ALLY/financials
- Thesis: /stocks/ALLY/thesis
- Investment Memo: /stocks/ALLY/memo
- Coverage universe: /stocks